Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Analgesics Market Outlook 

The global analgesics market size attained a value of USD 71.90 billion in 2023 driven by increasing cases of chronic pain due to the rising old age population past 60 years of age. The market is anticipated to grow at a CAGR of 4.5% during the forecast period of 2024-2032 to attain a value of USD 106.84 billion by 2032.

Analgesics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The global analgesics market is driven by the increasing geriatric population globally. In 2017, the people over the age of 60, were recorded to be 950-1000 million. By the year 2050, these numbers are expected to grow rapidly to reach 2100 million, accounting for about 21% of the overall global population. Due to their susceptibility to chronic and lifestyle diseases, the rising population of older people will substantially contribute to the sales of analgesics. Further, permission by the United States Food and Drug Administration (USFDA) for the utilisation of a strong drug pipeline with efficacious drugs is expected to aid the analgesics market growth in the forecast period.

Analgesics Market by Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Properties and Applications

Analgesics is referred to as a type of drug intended to relieve or control pain. Several of these drugs work on the body’s peripheral and central nervous systems to mitigate or block sensitivity to pain. However, some of the analgesics act by inhibiting the formation of certain chemicals in the body that mediate pain. These painkillers are prescription-only medicines, available only on doctor’s instruction and recommendation. These are used to treat moderate to severe pain, including backache, along with neck, pre-menstrual and menstrual, and muscle pain.

The analgesics market is divided on the basis of type into:

  • Prescription Analgesics
  • OTC Analgesics

On the basis of drug class, the analgesics market is divided into:

  • Opioids
  • NSAID
  • Others

On the basis of ROA, the analgesics market is segmented into:

  • Oral
  • Parenteral
  • Topical
  • Transdermal
  • Rectal

On the basis of pain type, the analgesics market is divided into:

  • Musculoskeletal Pain
  • Surgical and Trauma Pain
  • Cancer Pain
  • Neuropathic Pain
  • Migraine
  • Obstetrical Pain
  • Fibromyalgia
  • Pain due to Burns
  • Dental/Facial Pain
  • Paediatric Pain
  • Others

On the basis of application, the analgesics market is bifurcated into:

  • Internal Analgesics
  • External Analgesics

The report also covers the regional analgesics markets like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Analgesics Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

The global analgesics market is driven by the increasing cases of chronic pain due to the rising old age population past 60 years of age. The growing proportion of older people will contribute significantly to the sales of analgesics. In addition to this, healthcare companies are investing in research and development activities to advance the combination of existing compounds to develop novel analgesics with enhanced efficacy and reduced side effects. Furthermore, with the launch of a national education campaign by the United States Food and Drug Administration (USFDA) to offer guidance to patients and create awareness among the patients about the safe use of OTC analgesics, has resulted in the increased demand for these medicines, thereby propelling the industry growth in the region.

Competitive Landscape

The report gives a detailed analysis of the following key players in the global analgesics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Bayer AG  
  • GlaxoSmithKline PLC 
  • Pfizer Inc. 
  • Sanofi 
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Drug Class
  • Route of Administration
  • Pain Type
  • Application
  • End User
  • Region
Breakup by Type
  • Prescription Analgesics
  • OTC Analgesics
Breakup by Drug Class
  • Opioids
  • NSAID
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Topical
  • Transdermal
  • Rectal
Breakup by Pain Type
  • Musculoskeletal Pain
  • Surgical and Trauma Pain
  • Cancer Pain
  • Neuropathic Pain
  • Migraine
  • Obstetrical Pain
  • Fibromyalgia
  • Pain due to burns
  • Dental/Facial Pain
  • Pediatric Pain
  • Others
Breakup by Application
  • Internal Analgesics
  • External Analgesics
Breakup by End User
  • Hospital Pharmacy
  • Retail Pharmacy
  • Other
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Bayer AG
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Sanofi
  • F. Hoffmann-La Roche Ltd.
  • Endo Pharmaceuticals, Inc.
  • Bristol-Myers Squibb Company
  • Assertio Therapeutics, Inc.
  • Janssen Pharmaceuticals
  • Novartis AG
  • Teva Pharmaceuticals
  • AbbVie Inc.
  • Purdue Pharmaceuticals L.P.
  • Boehringer Ingelheim International GmbH

Analgesics Market Report Snapshots

Analgesics Market Size

Analgesics Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

Globally, analgesics market reached a value of USD 71.90 billion in 2023.

The market is projected to expand at a CAGR of 4.5% from 2024 to 2032, growing to USD 106.84 billion by 2032.

The major drivers of the industry such as rising disposable incomes, increasing population, increasing health consciousness, and increasing geriatric population are expected to aid the industry growth.

The rising R&D activities aimed at producing more effective analgesics with lesser side effects is a major trend guiding the growth of the market.

The major regional markets for the product are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The leading types of the product in the industry are prescription and OTC analgesics.

Opioids and NSAID, among others, are the leading drug classes available in the market.

The leading ROA types in the industry are into oral, parenteral, topical, transdermal, and rectal.

The major pain types covered in the report are musculoskeletal pain, surgical and trauma pain, cancer pain, neuropathic pain, migraine, obstetrical pain, fibromyalgia, pain due to burns, dental/facial pain, paediatric pain, and others.

The leading applications of the product are internal and external analgesics.

The major players in the industry are Bayer AG, GlaxoSmithKline PLC, Pfizer Inc., Sanofi, and others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124